Compass Pathways Plc buy BiotechBee
Start price
08.06.25
/
60%
€4.26
Target price
31.08.27
€8.00
Performance (%)
-43.66%
End price
29.06.25
€2.40
Summary
This prediction ended on 29.06.25 with a price of €2.40. Massive losses of -43.66% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Compass Pathways Plc | - | - |
| iShares Core DAX® | 2,49 % | -5,94 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % |
| iShares S&P 500 | 1,35 % | -2,94 % |
According to BiotechBee what are the pros and cons of Compass Pathways Plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year